The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate cancer, according to an industry press release.
On International Women’s Day, we celebrate technology pioneers and recognize the mentorship that is necessary to inspire the current generation and those of the future.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results